Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Biohaven Pharmaceutical Holding Total Assets 2016-2021 | BHVN

Biohaven Pharmaceutical Holding total assets from 2016 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Biohaven Pharmaceutical Holding total assets for the quarter ending March 31, 2021 were $1.003B, a 88.33% increase year-over-year.
  • Biohaven Pharmaceutical Holding total assets for 2020 were $0.687B, a 99.55% increase from 2019.
  • Biohaven Pharmaceutical Holding total assets for 2019 were $0.344B, a 18.71% increase from 2018.
  • Biohaven Pharmaceutical Holding total assets for 2018 were $0.29B, a 97.44% increase from 2017.
  
Biohaven Pharmaceutical Holding Annual Total Assets
(Millions of US $)
2020 $687
2019 $344
2018 $290
2017 $147
2016 $27
2015 $2
Biohaven Pharmaceutical Holding Quarterly Total Assets
(Millions of US $)
2021-03-31 $1,003
2020-12-31 $687
2020-09-30 $782
2020-06-30 $424
2020-03-31 $533
2019-12-31 $344
2019-09-30 $439
2019-06-30 $491
2019-03-31 $245
2018-12-31 $290
2018-09-30 $195
2018-06-30 $239
2018-03-31 $126
2017-12-31 $147
2017-09-30 $185
2017-06-30 $214
2017-03-31 $60
2016-12-31 $27
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31 $2
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.834B $0.064B
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company's pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.360B 10.42
Amgen (AMGN) United States $139.484B 15.05
CSL (CSLLY) Australia $104.441B 0.00
Moderna (MRNA) United States $87.874B 175.08
Gilead Sciences (GILD) United States $86.250B 9.18
Illumina (ILMN) United States $66.163B 95.40
Biogen (BIIB) United States $59.716B 13.67
BioNTech SE (BNTX) Germany $57.615B 41.78
Regeneron Pharmaceuticals (REGN) United States $55.994B 16.03
Vertex Pharmaceuticals (VRTX) United States $49.966B 20.58
Alexion Pharmaceuticals (ALXN) United States $40.148B 15.25
BeiGene (BGNE) Cayman Islands $31.850B 0.00
Genmab (GMAB) Denmark $28.702B 33.65
Seagen (SGEN) United States $28.416B 49.08
Genmab (GNMSF) Denmark $26.975B 6.20
Horizon Therapeutics Public (HZNP) Ireland $20.969B 26.81
Exact Sciences (EXAS) United States $20.910B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.827B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.397B 0.00
CureVac (CVAC) Germany $18.284B 0.00
Incyte (INCY) United States $18.161B 35.90
Bio-Techne Corp (TECH) United States $17.266B 90.79
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
ARGENX SE-ADR (ARGX) Netherlands $16.144B 0.00
Zai Lab (ZLAB) China $16.099B 0.00
Novavax (NVAX) United States $15.536B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.998B 136.78
Guardant Health (GH) United States $12.230B 0.00
QIAGEN (QGEN) Netherlands $10.914B 19.38
Repligen (RGEN) United States $10.515B 94.81
CRISPR Therapeutics AG (CRSP) Switzerland $9.623B 0.00
Denali Therapeutics (DNLI) United States $9.089B 326.09
Mirati Therapeutics (MRTX) United States $8.850B 0.00
Fate Therapeutics (FATE) United States $8.440B 0.00
Acceleron Pharma (XLRN) United States $8.100B 0.00
Exelixis (EXEL) United States $7.202B 114.90
AbCellera Biologics (ABCL) $7.017B 0.00
Ascendis Pharma (ASND) Denmark $7.011B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.864B 0.00
Sarepta Therapeutics (SRPT) United States $6.861B 0.00
Halozyme Therapeutics (HALO) United States $6.093B 33.43
Vir Biotechnology (VIR) United States $5.921B 0.00
Intellia Therapeutics (NTLA) United States $5.813B 0.00
Twist Bioscience (TWST) United States $5.605B 0.00
Beam Therapeutics (BEAM) United States $5.554B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.460B 19.78
Adaptive Biotechnologies (ADPT) United States $5.438B 0.00
Legend Biotech (LEGN) United States $5.307B 0.00
Reata Pharmaceuticals (RETA) United States $5.296B 0.00
I-Mab (IMAB) China $5.200B 0.00
Galapagos (GLPG) Belgium $5.198B 0.00
NeoGenomics (NEO) United States $5.083B 862.00
Blueprint Medicines (BPMC) United States $5.070B 15.44
Apellis Pharmaceuticals (APLS) United States $5.000B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.392B 0.00
Certara (CERT) United States $4.118B 0.00
SpringWorks Therapeutics (SWTX) United States $4.034B 0.00
Alkermes (ALKS) Ireland $4.016B 0.00
Arvinas (ARVN) United States $3.999B 0.00
Arena Pharmaceuticals (ARNA) United States $3.957B 0.00
Emergent Biosolutions (EBS) United States $3.403B 6.78
Intra-Cellular Therapies (ITCI) United States $3.385B 0.00
Berkeley Lights (BLI) United States $3.256B 0.00
Insmed (INSM) United States $3.111B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.873B 0.00
Amicus Therapeutics (FOLD) United States $2.826B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.815B 0.00
MorphoSys AG (MOR) Germany $2.694B 0.00
Vericel (VCEL) United States $2.669B 719.75
Sorrento Therapeutics (SRNE) United States $2.549B 0.00
Editas Medicine (EDIT) United States $2.538B 0.00
Global Blood Therapeutics (GBT) United States $2.531B 0.00
ALX Oncology Holdings (ALXO) United States $2.400B 0.00
Bluebird Bio (BLUE) United States $2.300B 0.00
Myriad Genetics (MYGN) United States $2.291B 0.00
Morphic Holding (MORF) United States $2.287B 0.00
Kymera Therapeutics (KYMR) United States $2.276B 0.00
Instil Bio (TIL) United States $2.189B 0.00
Heska (HSKA) United States $2.150B 937.36
Revance Therapeutics (RVNC) United States $2.146B 0.00
Bionano Genomics (BNGO) United States $2.114B 0.00
Myovant Sciences (MYOV) United Kingdom $2.067B 0.00
Ligand Pharmaceuticals (LGND) United States $2.059B 34.44
Deciphera Pharmaceuticals (DCPH) United States $2.053B 0.00
Seer (SEER) $2.033B 0.00
Prothena (PRTA) Ireland $1.992B 0.00
Atea Pharmaceuticals (AVIR) United States $1.966B 0.00
Amarin (AMRN) Ireland $1.954B 0.00
Inovio Pharmaceuticals (INO) United States $1.906B 0.00
Seres Therapeutics (MCRB) United States $1.883B 0.00
C4 Therapeutics (CCCC) United States $1.822B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.820B 0.00
Castle Biosciences (CSTL) United States $1.801B 0.00
Arcus Biosciences (RCUS) United States $1.767B 0.00
Genetron Holdings (GTH) China $1.759B 0.00
Zymeworks (ZYME) Canada $1.742B 0.00
Protagonist Therapeutics (PTGX) United States $1.742B 0.00
Sangamo Therapeutics (SGMO) United States $1.692B 0.00
PHARMA MAR SA (PHMMF) Spain $1.691B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.691B 0.00
BioAtla (BCAB) United States $1.675B 0.00
UniQure (QURE) Netherlands $1.659B 0.00
PureTech Health (PRTC) United States $1.651B 0.00
REGENXBIO (RGNX) United States $1.602B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.581B 0.00
Alector (ALEC) United States $1.565B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.530B 0.00
Precigen (PGEN) United States $1.513B 0.00
Cytokinetics (CYTK) United States $1.509B 0.00
Codexis (CDXS) United States $1.415B 0.00
NGM Biopharmaceuticals (NGM) United States $1.409B 0.00
Avid Bioservices (CDMO) United States $1.406B 0.00
Zealand Pharma (ZEAL) Denmark $1.392B 0.00
Northwest Biotherapeutics (NWBO) United States $1.348B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.319B 0.00
Nurix Therapeutics (NRIX) United States $1.284B 0.00
Ocugen (OCGN) United States $1.257B 0.00
Shattuck Labs (STTK) United States $1.250B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.247B 0.00
Repare Therapeutics (RPTX) Canada $1.237B 0.00
MiMedx (MDXG) United States $1.235B 0.00
Celldex Therapeutics (CLDX) United States $1.230B 0.00
Keros Therapeutics (KROS) United States $1.193B 0.00
Pliant Therapeutics (PLRX) United States $1.185B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Agenus (AGEN) United States $1.152B 0.00
Mesoblast (MESO) Australia $1.107B 0.00
Coherus BioSciences (CHRS) United States $1.098B 0.00
Scholar Rock Holding (SRRK) United States $1.089B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.083B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.066B 33.65
Dynavax Technologies (DVAX) United States $1.052B 0.00
Mersana Therapeutics (MRSN) United States $1.036B 0.00
MannKind (MNKD) United States $1.009B 0.00
VBI Vaccines (VBIV) United States $1.002B 0.00
Avidity Biosciences (RNA) United States $0.965B 0.00
Inhibrx (INBX) United States $0.923B 0.00
Travere Therapeutics (TVTX) United States $0.912B 0.00
G1 THERAPEUTICS (GTHX) United States $0.910B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.905B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.905B 0.00
Merus (MRUS) Netherlands $0.887B 0.00
Epizyme (EPZM) United States $0.870B 0.00
Sutro Biopharma (STRO) United States $0.856B 0.00
Prometheus Biosciences (RXDX) United States $0.833B 0.00
Nkarta (NKTX) United States $0.822B 0.00
Affimed (AFMD) Germany $0.801B 0.00
Pharming Group (PHGUF) Netherlands $0.789B 21.00
Pharming Group (PHAR) Netherlands $0.775B 0.00
Verastem (VSTM) United States $0.774B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.762B 0.00
SESEN BIO, INC (SESN) United States $0.736B 0.00
Curis (CRIS) United States $0.733B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.722B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.715B 0.00
Kadmon Holdings (KDMN) United States $0.707B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.703B 0.00
ChromaDex (CDXC) United States $0.699B 0.00
Cara Therapeutics (CARA) United States $0.699B 60.70
Adaptimmune Therapeutics (ADAP) United Kingdom $0.693B 0.00
Cellectis S.A (CLLS) France $0.690B 0.00
IDEAYA Biosciences (IDYA) United States $0.687B 0.00
DBV Technologies S.A (DBVT) France $0.671B 0.00
AnaptysBio (ANAB) United States $0.665B 0.00
Clene (CLNN) United States $0.664B 0.00
Precision BioSciences (DTIL) United States $0.663B 0.00
MeiraGTx Holdings (MGTX) United States $0.660B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
ALBIREO PHARMA (ALBO) United States $0.639B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.634B 0.00
Anika Therapeutics (ANIK) United States $0.624B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.621B 0.00
Inventiva S.A (IVA) France $0.605B 0.00
Clovis Oncology (CLVS) United States $0.604B 0.00
Bolt Biotherapeutics (BOLT) United States $0.595B 0.00
Codiak BioSciences (CDAK) United States $0.591B 0.00
Adagene (ADAG) China $0.589B 0.00
Selecta Biosciences (SELB) United States $0.563B 0.00
AC Immune SA (ACIU) Switzerland $0.558B 0.00
Forte Biosciences (FBRX) United States $0.552B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.545B 0.00
Compugen (CGEN) Israel $0.543B 0.00
Starpharma Holdings (SPHRY) Australia $0.542B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.510B 0.00
XBiotech (XBIT) United States $0.509B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.503B 0.00
Gritstone Bio (GRTS) United States $0.495B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Athenex (ATNX) United States $0.469B 0.00
CytomX Therapeutics (CTMX) United States $0.465B 0.00
RAPT THERAPTICS (RAPT) United States $0.464B 0.00
Geron (GERN) United States $0.459B 0.00
Puma Biotechnology (PBYI) United States $0.458B 0.00
Spero Therapeutics (SPRO) United States $0.457B 0.00
Oncobiologics (OTLK) United States $0.451B 0.00
BeyondSpring (BYSI) United States $0.447B 0.00
Neoleukin Therapeutics (NLTX) United States $0.440B 0.00
Fortress Biotech (FBIO) United States $0.437B 0.00
AquaBounty Technologies (AQB) United States $0.433B 0.00
ANI Pharmaceuticals (ANIP) United States $0.431B 11.89
Amryt Pharma (AMYT) United Kingdom $0.419B 0.00
Cue Biopharma (CUE) United States $0.418B 0.00
Kala Pharmaceuticals (KALA) United States $0.409B 0.00
Angion Biomedica (ANGN) United States $0.399B 0.00
Opthea (OPT) Australia $0.387B 0.00
SQZ Biotechnologies (SQZ) United States $0.378B 0.00
Adicet Bio (ACET) United States $0.374B 0.00
Syros Pharmaceuticals (SYRS) United States $0.366B 0.00
Adverum Biotechnologies (ADVM) United States $0.364B 0.00
Athersys (ATHX) United States $0.362B 0.00
UROGEN PHARMA (URGN) United States $0.362B 0.00
WAVE Life Sciences (WVE) Singapore $0.361B 0.00
BioDelivery Sciences (BDSI) United States $0.360B 14.60
XOMA (XOMA) United States $0.356B 166.05
Trevena (TRVN) United States $0.348B 0.00
Prima BioMed (IMMP) Australia $0.342B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.339B 0.00
Theratechnologies (THTX) Canada $0.335B 0.00
Cerecor (CERC) United States $0.330B 0.00
Frequency Therapeutics (FREQ) United States $0.330B 0.00
Innate Pharma S.A (IPHA) France $0.327B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.324B 0.00
Arbutus Biopharma (ABUS) United States $0.316B 0.00
CorMedix Inc (CRMD) United States $0.313B 0.00
Cogent Biosciences (COGT) United States $0.312B 0.00
OVID THERAPEUTC (OVID) United States $0.304B 2.99
Talis Biomedical (TLIS) United States $0.299B 0.00
Cardiff Oncology (CRDF) United States $0.296B 0.00
Kindred Biosciences (KIN) United States $0.288B 0.00
Kaleido Biosciences (KLDO) $0.287B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Fulcrum Therapeutics (FULC) United States $0.282B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.273B 0.00
Bellus Health (BLU) Canada $0.270B 0.00
INmune Bio (INMB) United States $0.267B 0.00
Seelos Therapeutics (SEEL) United States $0.264B 0.00
Kamada (KMDA) Israel $0.263B 17.88
HOOKIPA Pharma (HOOK) United States $0.257B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.248B 0.00
Chiasma (CHMA) United States $0.243B 0.00
Aptinyx (APTX) United States $0.239B 0.00
Checkpoint Therapeutics (CKPT) United States $0.238B 0.00
ADMA Biologics Inc (ADMA) United States $0.233B 0.00
NextCure (NXTC) United States $0.222B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.220B 0.00
VTv Therapeutics (VTVT) United States $0.217B 0.00
X4 Pharmaceuticals (XFOR) United States $0.207B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Synlogic (SYBX) United States $0.194B 0.00
Strongbridge Biopharma (SBBP) United States $0.193B 0.00
OSMOTICA PHARM (OSMT) United States $0.192B 0.00
Biofrontera AG (BFRA) Germany $0.190B 0.00
GENFIT S.A (GNFT) France $0.187B 0.00
TELA Bio (TELA) United States $0.184B 0.00
ObsEva SA (OBSV) Switzerland $0.184B 0.00
Applied Genetic Technologies (AGTC) United States $0.182B 0.00
Abeona Therapeutics (ABEO) United States $0.180B 0.00
Voyager Therapeutics (VYGR) United States $0.178B 4.59
Clearside Biomedical (CLSD) United States $0.173B 0.00
Galena Biopharma (SLS) United States $0.172B 0.00
Nicox SA (NICXF) France $0.171B 0.00
DiaMedica Therapeutics (DMAC) United States $0.168B 0.00
PHASEBIO PHARMA (PHAS) United States $0.168B 0.00
Eton Pharmaceuticals (ETON) United States $0.166B 0.00
Yumanity Therapeutics (YMTX) United States $0.165B 0.00
Antibe Therapeutics (ATBPF) Canada $0.163B 0.00
Enzo Biochem (ENZ) United States $0.149B 44.00
Exicure (XCUR) United States $0.148B 0.00
LogicBio Therapeutics (LOGC) United States $0.148B 0.00
Liminal BioSciences (LMNL) Canada $0.145B 0.00
Liquidia Technologies (LQDA) United States $0.141B 0.00
Catalyst Biosciences (CBIO) United States $0.141B 0.00
Erytech Pharma SA (ERYP) France $0.141B 0.00
Eyenovia (EYEN) United States $0.141B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.139B 0.00
Pluristem Therapeutics (PSTI) Israel $0.138B 0.00
Aytu BioPharma (AYTU) United States $0.137B 0.00
Novogen (KZIA) Australia $0.136B 0.00
Cyclerion Therapeutics (CYCN) United States $0.136B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.134B 0.00
Longeveron (LGVN) United States $0.134B 0.00
Orgenesis (ORGS) United States $0.134B 273.50
Celsion (CLSN) United States $0.133B 0.00
Evofem Biosciences (EVFM) United States $0.129B 0.00
ABVC BioPharma (ABVC) United States $0.127B 0.00
Vascular Biogenics (VBLT) Israel $0.125B 0.00
Cocrystal Pharma (COCP) United States $0.122B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.120B 0.00
Aptevo Therapeutics (APVO) United States $0.115B 0.00
Beyond Air (XAIR) United States $0.113B 0.00
Vyant Bio (VYNT) United States $0.109B 0.00
ARAVIVE, INC (ARAV) United States $0.109B 0.00
CytRx (CYTR) United States $0.108B 0.00
Leap Therapeutics (LPTX) United States $0.107B 0.00
Cidara Therapeutics (CDTX) United States $0.104B 0.00
Dyadic (DYAI) United States $0.101B 0.00
TRACON Pharmaceuticals (TCON) United States $0.101B 0.00
Zosano Pharma (ZSAN) United States $0.100B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.098B 0.00
AIkido Pharma (AIKI) United States $0.098B 0.00
Lumos Pharma (LUMO) United States $0.096B 0.00
Evogene (EVGN) Israel $0.093B 0.00
Cleveland BioLabs (CBLI) United States $0.090B 0.00
Entera Bio (ENTX) Israel $0.090B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.089B 0.00
Purple Biotech (PPBT) Israel $0.088B 0.00
Celyad SA (CYAD) Belgium $0.083B 0.00
ARIDIS PHARMACT (ARDS) United States $0.078B 0.00
Edesa Biotech (EDSA) Canada $0.077B 0.00
Adocia (ADOCY) France $0.077B 0.00
ATyr Pharma (LIFE) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.075B 0.00
BioCardia (BCDA) United States $0.073B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
Advaxis (ADXS) United States $0.071B 0.00
Emmaus Life Sciences (EMMA) United States $0.071B 0.00
Cyclo Therapeutics (CYTH) United States $0.069B 0.00
Genetic Technologies (GENE) Australia $0.068B 0.00
AEterna Zentaris (AEZS) United States $0.066B 0.00
Idera Pharmaceuticals (IDRA) United States $0.066B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.065B 0.00
Pulmatrix (PULM) United States $0.064B 0.00
Windtree Therapeutics (WINT) United States $0.064B 0.00
Viridian Therapeutics (VRDN) United States $0.063B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Invo BioScience (INVO) United States $0.054B 0.00
AnPac Bio-Medical Science (ANPC) China $0.054B 0.00
Enveric Biosciences (ENVB) United States $0.051B 0.00
Soligenix (SNGX) United States $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.043B 0.00
Benitec Biopharma (BNTC) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.88
ThermoGenesis Holdings (THMO) United States $0.035B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.034B 0.00
GeoVax Labs (GOVX) United States $0.034B 0.00
Vallon Pharmaceuticals (VLON) United States $0.034B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
ZIVO Bioscience (ZIVO) United States $0.025B 0.00
Palisade Bio (PALI) United States $0.012B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00